INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $272,000 | -11.7% | 204,399 | +250.0% | 0.08% | -8.5% |
Q1 2016 | $308,000 | -70.8% | 58,399 | -56.5% | 0.08% | -70.8% |
Q4 2015 | $1,053,000 | -14.9% | 134,099 | -8.4% | 0.28% | +6.0% |
Q3 2015 | $1,238,000 | -18.7% | 146,473 | +5.3% | 0.26% | -5.0% |
Q2 2015 | $1,523,000 | +6.4% | 139,091 | +35.9% | 0.28% | +2.2% |
Q1 2015 | $1,431,000 | – | 102,331 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |